Breaking News

Biosimilar Global Market by Product, Scope, Analysis and Outlook to 2022


According to Publisher, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs has experienced robust market growth. Some of the factors which are triggering the market growth include growing incidences of diseases, rising demand for biosimilars drugs owing to their cost effectiveness and increasing demand to limit healthcare expenditures. However, stringent government regulations will affect biosimilars investments.

Chronic & Autoimmune disorders segment is expected to grow at a highest CAGR during the forecast period owing to increasing incidences of autoimmune disorders. By geography, Europe dominated the global biosimilars market due to growing appearance of new market participants in this region. However, Asia Pacific is anticipated to grow at a highest CAGR during the forecast period due to rising funds towards the expansion of biosimilars market.

Also Read:  Infibeam to sell Infinium to Ingenius E-commerce for $8.4 Mn

For more information @

Some of the key players in this market include are Mylan, Inc., Dr. Reddy’s Laboratories, Amgen Inc., Sandoz International GmbH , Hospira, Inc., Merck KGAA, Celltrion, Inc., Biocon Ltd. , Teva Pharmaceutical Industries Ltd. and Roche Diagnostics.

Products Covered:
– Peptides
– Erythropoietin
– Interferon
– Human Growth Hormone
– Monoclonal Antibodies
– Granulocyte Colony Stimulating Factor (G-CSF)
– Insulin
– Other Products

Technology Covered:
– Bioassay
– Mass Spectrometry
– Nuclear magnetic resonance (NMR) technology
– Recombinant DNA Technology (rDNA technology)
– Western Blotting
– Electrophoresis
– Chromatography
– Monoclonal Antibodies (MAb) Technology

Application Covered:
– Growth Hormone Deficiency
– Chronic and Autoimmune Diseases
– Blood Disorders
– Oncology Diseases
– Other Applications

Service Covered:
– Clinical Trials
– Contract Research and Manufacturing Services

Also Read:  Infibeam to sell Infinium to Ingenius E-commerce for $8.4 Mn

Request Sample Copy

Regions Covered:
– North America
o US
o Canada
o Mexico
– Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
– Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
– Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

11 Company Profiling
11.1 Mylan, Inc.
11.2 Dr. Reddy’s Laboratories
11.3 Amgen Inc.
11.4 Sandoz International GmbH
11.5 Hospira, Inc.
11.6 Merck KGAA
11.7 Celltrion, Inc.
11.8 Biocon Ltd.
11.9 Teva Pharmaceutical Industries Ltd.
11.10 Roche Diagnostics
11.11 Biogen idec Inc.
11.12 LG Life Sciences
11.13 Synthon Pharmaceuticals, Inc.
11.14 Novartis AG

Make an enquiry:

Contact Us:

Call: +1-646-491-9876


Go to website